MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.33M | 1.68M | 1.76M | 1.85M | 1.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -571.10K | 193.90K | 364.10K |
| Total Operating Expenses | 3.22M | 2.88M | 2.71M | 3.18M | 4.05M |
| Operating Income | -3.22M | -2.88M | -2.71M | -3.18M | -4.05M |
| Income Before Tax | -3.13M | -2.74M | -2.60M | -2.89M | -4.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.13M | -2.74M | -2.60M | -2.89M | -4.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.13M | -2.74M | -2.60M | -2.89M | -4.24M |
| EBIT | -3.22M | -2.88M | -2.71M | -3.18M | -4.05M |
| EBITDA | -3.18M | -2.85M | -2.67M | -3.14M | -4.00M |
| EPS Basic | -0.62 | -0.57 | -0.56 | -0.65 | -1.06 |
| Normalized Basic EPS | -0.39 | -0.36 | -0.35 | -0.41 | -0.67 |
| EPS Diluted | -0.62 | -0.57 | -0.56 | -0.65 | -1.06 |
| Normalized Diluted EPS | -0.39 | -0.36 | -0.35 | -0.41 | -0.67 |
| Average Basic Shares Outstanding | 5.02M | 4.80M | 4.69M | 4.44M | 3.98M |
| Average Diluted Shares Outstanding | 5.02M | 4.80M | 4.69M | 4.44M | 3.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |